Literature DB >> 24217529

[Current management of renal artery stenosis].

T Lenz1.   

Abstract

Severe renal artery stenosis may cause renovascular hypertension; in case of bilateral narrowing or in a stenotic solitary kidney, renal insufficiency (ischemic kidney disease) or rarely pulmonary flush edema may occur. Renal artery stenosis may be treated by revascularization, using either percutaneous (balloon angioplasty, stenting) or less common open surgical procedures, both with excellent primary patency rates. However, randomized trials of renal artery angioplasty or stenting have failed to demonstrate a longer-term benefit with regard to blood pressure control and renal function over medical management alone (except for fibromuscular disease). Furthermore, endovascular procedures are associated with substantial risks. It has not yet been demonstrated that renal revascularization leads to a prolongation of event-free survival. Careful patient selection is essential to maximize the potential benefit.

Entities:  

Mesh:

Year:  2013        PMID: 24217529     DOI: 10.1007/s00108-013-3324-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  34 in total

1.  Renal artery stenosis: "fortuitous diagnosis," problematic therapy.

Authors:  Larry A Weinrauch; John A D'Elia
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

Review 2.  Renovascular hypertension: balancing the controversies in diagnosis and treatment.

Authors:  Vesna D Garovic; Garvan C Kane; Gary L Schwartz
Journal:  Cleve Clin J Med       Date:  2005-12       Impact factor: 2.321

3.  Renovascular hypertension. Mechanisms, natural history and treatment.

Authors:  J C Hunt; C G Strong
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

4.  Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure.

Authors:  Bruce H Gray; Jeffrey W Olin; Mary Beth Childs; Timothy M Sullivan; J Michael Bacharach
Journal:  Vasc Med       Date:  2002       Impact factor: 3.239

5.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.

Authors:  J Radermacher; A Chavan; J Bleck; A Vitzthum; B Stoess; M J Gebel; M Galanski; K M Koch; H Haller
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

6.  A clinical prediction rule for renal artery stenosis.

Authors:  P Krijnen; B C van Jaarsveld; E W Steyerberg; A J Man in 't Veld; M A Schalekamp; J D Habbema
Journal:  Ann Intern Med       Date:  1998-11-01       Impact factor: 25.391

Review 7.  Contrast nephrotoxicity.

Authors:  B J Barrett
Journal:  J Am Soc Nephrol       Date:  1994-08       Impact factor: 10.121

8.  Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions.

Authors:  Thomas Zeller; Ulrich Frank; Christian Müller; Karlheinz Bürgelin; Lutz Sinn; Barbara Horn; Peter-Christian Flügel; Uwe Schwarzwälder; Helmut Roskamm; Franz-Josef Neumann
Journal:  J Endovasc Ther       Date:  2004-04       Impact factor: 3.487

9.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

Authors:  Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler
Journal:  Ann Intern Med       Date:  2009-05-04       Impact factor: 25.391

10.  Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis.

Authors:  Thomas Zeller; Christian Müller; Ulrich Frank; Karlheinz Bürgelin; Barbara Horn; Uwe Schwarzwälder; Nancy Cook-Bruns; Franz-Josef Neumann
Journal:  Catheter Cardiovasc Interv       Date:  2003-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.